{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:00:40Z","timestamp":1777518040221,"version":"3.51.4"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T00:00:00Z","timestamp":1444953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s11882-015-0569-2","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T06:08:06Z","timestamp":1444975686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis"],"prefix":"10.1007","volume":"15","author":[{"given":"Whitney","family":"Stevens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Buchheit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine N.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,16]]},"reference":[{"key":"569_CR1","doi-asserted-by":"crossref","unstructured":"Cahill KN et al. Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135(1):245\u201352. This is an original article demonstrating the role of PGD 2 in aspirin-induced rash and gastrointestinal symptoms in AERD. Additionally, it demonstrates the suppressive effect of high-dose aspirin therapy on PGD 2 and a connection with eosinophilia.","DOI":"10.1016\/j.jaci.2014.07.031"},{"issue":"1","key":"569_CR2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2013.07.004","volume":"133","author":"G Bochenek","year":"2014","unstructured":"Bochenek G et al. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. J Allergy Clin Immunol. 2014;133(1):98\u2013103.e1-6.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"569_CR3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaip.2015.01.007","volume":"3","author":"K Lee-Sarwar","year":"2015","unstructured":"Lee-Sarwar K et al. Tolerance of daily low-dose aspirin does not preclude aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;3(3):449\u201351.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"569_CR4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2014.02.041","volume":"134","author":"M Swierczynska-Krepa","year":"2014","unstructured":"Swierczynska-Krepa M et al. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study. J Allergy Clin Immunol. 2014;134(4):883\u201390.","journal-title":"J Allergy Clin Immunol"},{"key":"569_CR5","doi-asserted-by":"crossref","unstructured":"Chen JR, Buchmiller BL, Khan DA. An hourly dose-escalation desensitization protocol for aspirin exacerbated respiratory disease. J Allergy Clin Immunol. 2015.","DOI":"10.1016\/j.jaip.2015.06.013"},{"issue":"2","key":"569_CR6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaip.2013.12.003","volume":"2","author":"JC Cardet","year":"2014","unstructured":"Cardet JC. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol. 2014;2(2):208\u201313. The paper is an original research highlighting the frequency of alcohol-induced respiratory symptoms experienced by patients with AERD.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"569_CR7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.anai.2015.02.013","volume":"114","author":"CJ Calais","year":"2015","unstructured":"Calais CJ, Banks TA. Resolution of alcohol-induced respiratory symptoms following aspirin desensitization in aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2015;114(5):429\u201330.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"569_CR8","doi-asserted-by":"crossref","unstructured":"Ta V, White AA. Survey-defined patient experiences with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015.","DOI":"10.1016\/j.jaip.2015.03.001"},{"issue":"6","key":"569_CR9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2500\/ajra.2014.28.4103","volume":"28","author":"J Yip","year":"2014","unstructured":"Yip J, Yao CM, Lee JM. State of the art: a systematic review of the surgical management of aspirin exacerbated respiratory disease. Am J Rhinol Allergy. 2014;28(6):493\u2013501.","journal-title":"Am J Rhinol Allergy"},{"issue":"7","key":"569_CR10","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/MLG.0b013e318170af1e","volume":"118","author":"OG Awad","year":"2008","unstructured":"Awad OG et al. Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma? Laryngoscope. 2008;118(7):1282\u20136.","journal-title":"Laryngoscope"},{"issue":"5","key":"569_CR11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","volume":"116","author":"K Mascia","year":"2005","unstructured":"Mascia K et al. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2005;116(5):970\u20135.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"569_CR12","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/all.12629","volume":"70","author":"DR Morales","year":"2015","unstructured":"Morales DR et al. NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity. Allergy. 2015;70(7):828\u201335.","journal-title":"Allergy"},{"issue":"5","key":"569_CR13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.rmed.2015.02.015","volume":"109","author":"G Bochenek","year":"2015","unstructured":"Bochenek G et al. Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease. Respir Med. 2015;109(5):588\u201395.","journal-title":"Respir Med"},{"issue":"5","key":"569_CR14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","volume":"100","author":"AB Dursun","year":"2008","unstructured":"Dursun AB et al. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol. 2008;100(5):420\u20135.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"569_CR15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","volume":"89","author":"MP Berges-Gimeno","year":"2002","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2002;89(5):474\u20138.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"569_CR16","doi-asserted-by":"crossref","unstructured":"Woessner KM, White AA. Evidence-based approach to aspirin desensitization in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2014;133(1):286\u20137.e1-9.","DOI":"10.1016\/j.jaci.2013.11.016"},{"issue":"8","key":"569_CR17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s11882-015-0552-y","volume":"15","author":"J Makowska","year":"2015","unstructured":"Makowska J, Lewandowska-Polak A, Kowalski ML. Hypersensitivity to aspirin and other NSAIDs: diagnostic approach in patients with chronic rhinosinusitis. Curr Allergy Asthma Rep. 2015;15(8):552.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"569_CR18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2500\/aap.2013.34.3670","volume":"34","author":"AA White","year":"2013","unstructured":"White AA, Bosso JV, Stevenson DD. The clinical dilemma of \"silent desensitization\" in aspirin-exacerbated respiratory disease. Allergy Asthma Proc. 2013;34(4):378\u201382.","journal-title":"Allergy Asthma Proc"},{"issue":"6 Pt 1","key":"569_CR19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1081-1206(10)62575-6","volume":"85","author":"DD Stevenson","year":"2000","unstructured":"Stevenson DD et al. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol. 2000;85(6 Pt 1):477\u201382.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"569_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2500\/ajra.2015.29.4114","volume":"29","author":"V Ta","year":"2015","unstructured":"Ta V, Simon R. State of the art: medical treatment of aspirin exacerbated respiratory disease (AERD). Am J Rhinol Allergy. 2015;29(1):41\u20133.","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"569_CR21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.anai.2014.07.025","volume":"113","author":"AT Peters","year":"2014","unstructured":"Peters AT et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014;113(4):347\u201385.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"569_CR22","doi-asserted-by":"crossref","unstructured":"Humbert M et al. Omalizumab in asthma: an update on recent developments. J Allergy Clin Immunol. 2014;2(5):525\u201336.e1.","DOI":"10.1016\/j.jaip.2014.03.010"},{"key":"569_CR23","doi-asserted-by":"crossref","unstructured":"Gevaert P et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013;131(1):110\u20136.e1.","DOI":"10.1016\/j.jaci.2012.07.047"},{"key":"569_CR24","doi-asserted-by":"crossref","unstructured":"Gevaert P et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128(5):989\u201395.e1-8.","DOI":"10.1016\/j.jaci.2011.07.056"},{"issue":"6","key":"569_CR25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11882-014-0441-9","volume":"14","author":"L Klimek","year":"2014","unstructured":"Klimek L et al. Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)? Curr Allergy Asthma Rep. 2014;14(6):441.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"569_CR26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11882-014-0508-7","volume":"15","author":"RA Simon","year":"2015","unstructured":"Simon RA, Dazy KM, Waldram JD. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD). Curr Allergy Asthma Rep. 2015;15(3):508.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"569_CR27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13223-014-0064-7","volume":"10","author":"C Ibrahim","year":"2014","unstructured":"Ibrahim C et al. A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma. Allergy Asthma Clin Immunol. 2014;10(1):64.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"569_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","volume":"111","author":"MP Berges-Gimeno","year":"2003","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111(1):180\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"569_CR29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00405-012-2048-x","volume":"270","author":"M Havel","year":"2013","unstructured":"Havel M et al. Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad. Eur Arch Otorhinolaryngol. 2013;270(2):571\u20138.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"569_CR30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0194599814545750","volume":"151","author":"KS Cho","year":"2014","unstructured":"Cho KS et al. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease. Otolaryngol Head Neck Surg. 2014;151(4):575\u201381.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"569_CR31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaci.2006.09.011","volume":"119","author":"JY Lee","year":"2007","unstructured":"Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2007;119(1):157\u201364.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"569_CR32","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/all.12269","volume":"68","author":"S Comert","year":"2013","unstructured":"Comert S et al. Aspirin 300 mg\/day is effective for treating aspirin-exacerbated respiratory disease. Allergy. 2013;68(11):1443\u201351.","journal-title":"Allergy"},{"issue":"5","key":"569_CR33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/all.12131","volume":"68","author":"K Fruth","year":"2013","unstructured":"Fruth K et al. Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease. Allergy. 2013;68(5):659\u201365.","journal-title":"Allergy"},{"issue":"9","key":"569_CR34","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1398-9995.2008.01658.x","volume":"63","author":"A Rozsasi","year":"2008","unstructured":"Rozsasi A et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy. 2008;63(9):1228\u201334.","journal-title":"Allergy"},{"issue":"1","key":"569_CR35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1939-4551-7-18","volume":"7","author":"R Howe","year":"2014","unstructured":"Howe R et al. Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease. World Allergy Organ J. 2014;7(1):18.","journal-title":"World Allergy Organ J"},{"issue":"1","key":"569_CR36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0194599814555836","volume":"152","author":"DD Sommer","year":"2015","unstructured":"Sommer DD et al. Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study. Otolaryngol Head Neck Surg. 2015;152(1):42\u20137.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5949","key":"569_CR37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/bmj.1.5949.67","volume":"1","author":"A Szczeklik","year":"1975","unstructured":"Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J. 1975;1(5949):67\u20139.","journal-title":"Br Med J"},{"issue":"Suppl 1","key":"569_CR38","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1007\/BF00587792","volume":"297","author":"A Szczeklik","year":"1977","unstructured":"Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Participation of prostaglandins in pathogenesis of aspirin-sensitive asthma. Naunyn Schmiedeberg's Arch Pharmacol. 1977;297 Suppl 1:S99\u201310.","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"5","key":"569_CR39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6989(77)80027-1","volume":"9","author":"A Szczeklik","year":"1977","unstructured":"Szczeklik A et al. Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps. Pharmacol Res Commun. 1977;9(5):415\u201325.","journal-title":"Pharmacol Res Commun"},{"issue":"3","key":"569_CR40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1183\/09031936.93.06030391","volume":"6","author":"K Sladek","year":"1993","unstructured":"Sladek K, Szczeklik A. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J. 1993;6(3):391\u20139.","journal-title":"Eur Respir J"},{"issue":"11","key":"569_CR41","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/all.12512","volume":"69","author":"L Mastalerz","year":"2014","unstructured":"Mastalerz L et al. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity. Allergy. 2014;69(11):1550\u20139.","journal-title":"Allergy"},{"issue":"8","key":"569_CR42","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/all.12187","volume":"68","author":"P Campo","year":"2013","unstructured":"Campo P et al. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs. Allergy. 2013;68(8):1001\u20137.","journal-title":"Allergy"},{"issue":"7","key":"569_CR43","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/cea.12096","volume":"43","author":"GS Choi","year":"2013","unstructured":"Choi GS et al. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD. Clin Exp Allergy. 2013;43(7):730\u201340.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"569_CR44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.1301753","volume":"193","author":"JW Steinke","year":"2014","unstructured":"Steinke JW et al. Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease. J Immunol. 2014;193(1):41\u20137.","journal-title":"J Immunol"},{"issue":"16","key":"569_CR45","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","volume":"119","author":"TM Laidlaw","year":"2012","unstructured":"Laidlaw TM et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 2012;119(16):3790\u20138. The paper is an original research identifying elevated platelet-leukocyte aggregates in AERD and their role in cysteinyl leukotriene production.","journal-title":"Blood"},{"key":"569_CR46","doi-asserted-by":"crossref","unstructured":"Mitsui C et al. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015.","DOI":"10.1016\/j.jaci.2015.05.041"},{"issue":"6","key":"569_CR47","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jaci.2015.02.005","volume":"135","author":"TM Laidlaw","year":"2015","unstructured":"Laidlaw TM, Boyce JA. Platelets in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135(6):1407\u201314. This is a comprehensive review of our current understanding from human and mouse studies of the contribution of platelets to AERD.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"569_CR48","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","volume":"115","author":"CA Perez-Novo","year":"2005","unstructured":"Perez-Novo CA et al. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol. 2005;115(6):1189\u201396.","journal-title":"J Allergy Clin Immunol"},{"key":"569_CR49","doi-asserted-by":"crossref","unstructured":"Steinke JW et al. Prominent role of IFN-gamma in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2013;132(4):856\u201365.e1-3.","DOI":"10.1016\/j.jaci.2013.05.008"},{"key":"569_CR50","unstructured":"Stevens WW et al. Cytokines in chronic rhinosinusitis: role in eosinophilia and aspirin exacerbated respiratory disease. Am J Respir Crit Care Med. 2015. Comprehensive original study characterizing and comparing the inflammatory mediators present in nasal polyps of CRSwNP and AERD."},{"issue":"6","key":"569_CR51","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s10753-013-9699-7","volume":"36","author":"A Aktas","year":"2013","unstructured":"Aktas A, Kurt E, Gulbas Z. Cytokine expression before and after aspirin desensitization therapy in aspirin-exacerbated respiratory disease. Inflammation. 2013;36(6):1553\u20139.","journal-title":"Inflammation"},{"issue":"2","key":"569_CR52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2500\/aap.2014.35.3726","volume":"35","author":"K Aksu","year":"2014","unstructured":"Aksu K et al. Effect of aspirin desensitization on T-cell cytokines and plasma lipoxins in aspirin-exacerbated respiratory disease. Allergy Asthma Proc. 2014;35(2):148\u201355.","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"569_CR53","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/cea.12287","volume":"44","author":"S Baba","year":"2014","unstructured":"Baba S et al. Local increase in IgE and class switch recombination to IgE in nasal polyps in chronic rhinosinusitis. Clin Exp Allergy. 2014;44(5):701\u201312.","journal-title":"Clin Exp Allergy"},{"key":"569_CR54","doi-asserted-by":"crossref","unstructured":"Hulse KE et al. Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression. J Allergy Clin Immunol. 2013;131(4):1075\u201383.","DOI":"10.1016\/j.jaci.2013.01.043"},{"issue":"4","key":"569_CR55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2500\/ajra.2014.28.4054","volume":"28","author":"CB Johns","year":"2014","unstructured":"Johns CB, Laidlaw TM. Elevated total serum IgE in nonatopic patients with aspirin-exacerbated respiratory disease. Am J Rhinol Allergy. 2014;28(4):287\u20139.","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"569_CR56","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000353976","volume":"162","author":"HS Yoo","year":"2013","unstructured":"Yoo HS et al. Clinical significance of immunoglobulin E responses to staphylococcal superantigens in patients with aspirin-exacerbated respiratory disease. Int Arch Allergy Immunol. 2013;162(4):340\u20135.","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"569_CR57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000076832","volume":"133","author":"CA Perez-Novo","year":"2004","unstructured":"Perez-Novo CA et al. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. Int Arch Allergy Immunol. 2004;133(3):255\u201360.","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"569_CR58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2500\/aap.2006.27.2908","volume":"27","author":"JY Lee","year":"2006","unstructured":"Lee JY et al. Role of staphylococcal superantigen-specific IgE antibodies in aspirin-intolerant asthma. Allergy Asthma Proc. 2006;27(5):341\u20136.","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"569_CR59","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4168\/aair.2013.5.5.258","volume":"5","author":"SM Park","year":"2013","unstructured":"Park SM et al. Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways. Allergy Asthma Immunol Res. 2013;5(5):258\u201376.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"569_CR60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.aller.2014.06.004","volume":"43","author":"M Kurosawa","year":"2015","unstructured":"Kurosawa M et al. Recent advance in investigation of gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease. Allergol Immunopathol. 2015;43(1):92\u2013100.","journal-title":"Allergol Immunopathol"},{"issue":"12","key":"569_CR61","volume":"9","author":"SH Kim","year":"2014","unstructured":"Kim SH et al. The SNP rs3128965 of HLA-DPB1 as a genetic marker of the AERD phenotype. PLoS One. 2014;9(12), e111220.","journal-title":"PLoS One"},{"issue":"10","key":"569_CR62","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/01902148.2014.927939","volume":"40","author":"HS Chang","year":"2014","unstructured":"Chang HS et al. Association analysis of FABP1 gene polymorphisms with aspirin-exacerbated respiratory disease in asthma. Exp Lung Res. 2014;40(10):485\u201394.","journal-title":"Exp Lung Res"},{"issue":"3","key":"569_CR63","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/0194599814536369","volume":"151","author":"MS Benninger","year":"2014","unstructured":"Benninger MS, Holy CE. The impact of endoscopic sinus surgery on health care use in patients with respiratory comorbidities. Otolaryngol Head Neck Surg. 2014;151(3):508\u201315.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"7","key":"569_CR64","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/lary.25180","volume":"125","author":"KA Smith","year":"2015","unstructured":"Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: a systematic review. Laryngoscope. 2015;125(7):1547\u201356.","journal-title":"Laryngoscope"},{"issue":"3","key":"569_CR65","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","volume":"135","author":"JP Rajan","year":"2015","unstructured":"Rajan JP et al. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135(3):676\u2013681 e1. This paper is a comprehensive meta-analysis providing the most current estimates of the prevalence of AERD among patients with asthma, CRS, or nasal polyps.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"569_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2010-0031","volume":"33","author":"EA Townsend","year":"2012","unstructured":"Townsend EA, Miller VM, Prakash YS. Sex differences and sex steroids in lung health and disease. Endocr Rev. 2012;33(1):1\u201347.","journal-title":"Endocr Rev"},{"issue":"4","key":"569_CR67","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201107-1317PP","volume":"185","author":"NN Jarjour","year":"2012","unstructured":"Jarjour NN et al. Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med. 2012;185(4):356\u201362.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"569_CR68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/iid3.46","volume":"3","author":"WW Stevens","year":"2015","unstructured":"Stevens WW et al. A retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men. Immun Inflammation Dis. 2015;3(1):14\u201322.","journal-title":"Immun Inflammation Dis"},{"issue":"4","key":"569_CR69","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/jdv.12658","volume":"29","author":"M Sanchez-Borges","year":"2015","unstructured":"Sanchez-Borges M et al. Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2015;29(4):698\u2013701. This study identified a subset of NSAID-exacerbated cutaneous disease patients in a population of chronic spontaneous urticaria patients (53\/423) and found the patients with NSAID-exacerbated disease had longer duration of urticaria, more angioedema, and more atopy as compared to the NSAID-tolerant chronic spontaneous urticaria patients.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"569_CR70","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11882-005-0067-z","volume":"5","author":"L Mastalerz","year":"2005","unstructured":"Mastalerz L, Setkowicz M, Szczeklik A. Mechanism of chronic urticaria exacerbation by aspirin. Curr Allergy Asthma Rep. 2005;5(4):277\u201383.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"569_CR71","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaci.2008.09.005","volume":"123","author":"M Setkowicz","year":"2009","unstructured":"Setkowicz M et al. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. J Allergy Clin Immunol. 2009;123(1):174\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"569_CR72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1081-1206(10)62221-1","volume":"87","author":"DD Stevenson","year":"2001","unstructured":"Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol. 2001;87(3):177\u201380.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"569_CR73","first-page":"375","volume":"19","author":"M Sanchez-Borges","year":"2009","unstructured":"Sanchez-Borges M et al. The A-444C polymorphism in the leukotriene C4 synthase gene is associated with aspirin-induced urticaria. J Investig Allergol Clin Immunol. 2009;19(5):375\u201382.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4","key":"569_CR74","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2013.04.045","volume":"132","author":"C Vidal","year":"2013","unstructured":"Vidal C et al. Association of thromboxane A1 synthase (TBXAS1) gene polymorphism with acute urticaria induced by nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol. 2013;132(4):989\u201391.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"569_CR75","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/all.12458","volume":"69","author":"J Picaud","year":"2014","unstructured":"Picaud J et al. Anaphylaxis to diclofenac: nine cases reported to the Allergy Vigilance Network in France. Allergy. 2014;69(10):1420\u20133.","journal-title":"Allergy"},{"issue":"3","key":"569_CR76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1081-1206(10)63184-5","volume":"78","author":"J Quiralte","year":"1997","unstructured":"Quiralte J et al. Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies. Ann Allergy Asthma Immunol. 1997;78(3):293\u20136.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"569_CR77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.iac.2012.12.002","volume":"33","author":"KM Woessner","year":"2013","unstructured":"Woessner KM, Castells M. NSAID single-drug-induced reactions. Immunol Allergy Clin N Am. 2013;33(2):237\u201349.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"2","key":"569_CR78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/CRIAI:24:2:189","volume":"24","author":"RA Simon","year":"2003","unstructured":"Simon RA. Prevention and treatment of reactions to NSAIDs. Clin Rev Allergy Immunol. 2003;24(2):189\u201398.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"569_CR79","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12260","volume":"68","author":"ML Kowalski","year":"2013","unstructured":"Kowalski ML et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68(10):1219\u201332.","journal-title":"Allergy"},{"issue":"5","key":"569_CR80","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.anai.2014.08.017","volume":"113","author":"KN Cahill","year":"2014","unstructured":"Cahill KN, Laidlaw TM. Aspirin exacerbated respiratory disease: the search for a biomarker. Ann Allergy Asthma Immunol. 2014;113(5):500\u20131.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"569_CR81","first-page":"182","volume":"38","author":"AG Palma-Carlos","year":"2006","unstructured":"Palma-Carlos AG, Medina M, Palma-Carlos ML. Skin tests in NSAIDS hypersensitivity. Eur Ann Allergy Clin Immunol. 2006;38(6):182\u20135.","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"3","key":"569_CR82","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000319846","volume":"155","author":"P Korosec","year":"2011","unstructured":"Korosec P et al. Basophil responsiveness and clinical picture of acetylsalicylic acid intolerance. Int Arch Allergy Immunol. 2011;155(3):257\u201362.","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"569_CR83","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000222678","volume":"150","author":"S Bavbek","year":"2009","unstructured":"Bavbek S et al. Upregulation of CD63 or CD203c alone or in combination is not sensitive in the diagnosis of nonsteroidal anti-inflammatory drug intolerance. Int Arch Allergy Immunol. 2009;150(3):261\u201370.","journal-title":"Int Arch Allergy Immunol"},{"issue":"10","key":"569_CR84","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1365-2222.2009.03277.x","volume":"39","author":"GE Celik","year":"2009","unstructured":"Celik GE et al. Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease. Clin Exp Allergy. 2009;39(10):1522\u201331.","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"569_CR85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4168\/aair.2012.4.3.137","volume":"4","author":"MS Kim","year":"2012","unstructured":"Kim MS, Cho YJ. Flow cytometry-assisted basophil activation test as a safe diagnostic tool for aspirin\/NSAID hypersensitivity. Allergy Asthma Immunol Res. 2012;4(3):137\u201342.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"8","key":"569_CR86","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.96.8.2751","volume":"96","author":"CH Hennekens","year":"1997","unstructured":"Hennekens CH, Dyken ML, Fuster V. Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1997;96(8):2751\u20133.","journal-title":"Circulation"},{"issue":"7329","key":"569_CR87","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"C Antithrombotic Trialists","year":"2002","unstructured":"Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71\u201386.","journal-title":"BMJ"},{"issue":"23","key":"569_CR88","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJM200206063462309","volume":"346","author":"JM Gaspoz","year":"2002","unstructured":"Gaspoz JM et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002;346(23):1800\u20136.","journal-title":"N Engl J Med"},{"issue":"1","key":"569_CR89","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2007.06.047","volume":"121","author":"M Shaker","year":"2008","unstructured":"Shaker M et al. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2008;121(1):81\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"569_CR90","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.anai.2012.11.013","volume":"110","author":"CH Feng","year":"2013","unstructured":"Feng CH, White AA, Stevenson DD. Characterization of aspirin allergies in patients with coronary artery disease. Ann Allergy Asthma Immunol. 2013;110(2):92\u20135. This retrospective analysis of 9565 patients with coronary artery disease identified 142 patients (1.5\u00a0%) with listed aspirin allergy. Of the 142 patients, only 30 (21\u00a0%) had respiratory and\/or cutaneous reactions, while the remaining patients had adverse effects attributable to aspirin.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"569_CR91","doi-asserted-by":"crossref","unstructured":"Lanas A et al. Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin Gastroenterol Hepatol. 2011;9(9):762\u20138.e6.","DOI":"10.1016\/j.cgh.2011.05.020"},{"issue":"4","key":"569_CR92","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/ACI.0000000000000189","volume":"15","author":"KM Woessner","year":"2015","unstructured":"Woessner KM. Aspirin desensitization for cardiovascular disease. Curr Opin Allergy Clin Immunol. 2015;15(4):314\u201322.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"569_CR93","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.amjcard.2007.10.045","volume":"101","author":"R Rossini","year":"2008","unstructured":"Rossini R et al. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation. Am J Cardiol. 2008;101(6):786\u20139.","journal-title":"Am J Cardiol"},{"issue":"1","key":"569_CR94","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/clc.22054","volume":"36","author":"KL McMullan","year":"2013","unstructured":"McMullan KL, Wedner HJ. Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease. Clin Cardiol. 2013;36(1):25\u201330.","journal-title":"Clin Cardiol"},{"issue":"5","key":"569_CR95","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1067\/mai.2000.104571","volume":"105","author":"JT Wong","year":"2000","unstructured":"Wong JT et al. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol. 2000;105(5):997\u20131001.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"569_CR96","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijcard.2012.01.063","volume":"167","author":"G Luca De","year":"2013","unstructured":"De Luca G et al. Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. Int J Cardiol. 2013;167(2):561\u20133.","journal-title":"Int J Cardiol"},{"issue":"2","key":"569_CR97","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2500\/aap.2013.34.3644","volume":"34","author":"AA White","year":"2013","unstructured":"White AA et al. Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies. Allergy Asthma Proc. 2013;34(2):138\u201342.","journal-title":"Allergy Asthma Proc"},{"key":"569_CR98","unstructured":"Widal F, Abrami P, Lermoyez J. First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria)--1922 (with a note on aspirin desensitization). J Asthma. 1987;24(5):297\u2013300"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-015-0569-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-015-0569-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-015-0569-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T11:57:48Z","timestamp":1692100668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-015-0569-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,16]]},"references-count":98,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1007\/s11882-015-0569-2","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,16]]},"article-number":"69"}}